ABT logo

Abbott Laboratories (ABT) Net income

annual net income:

$13.40B+$7.68B(+134.18%)
December 31, 2024

Summary

  • As of today (April 16, 2025), ABT annual net profit is $13.40 billion, with the most recent change of +$7.68 billion (+134.18%) on December 31, 2024.
  • During the last 3 years, ABT annual net income has risen by +$6.33 billion (+89.53%).
  • ABT annual net income is now at all-time high.

Performance

ABT Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

quarterly net income:

$9.23B+$7.58B(+460.69%)
December 31, 2024

Summary

  • As of today (April 16, 2025), ABT quarterly net profit is $9.23 billion, with the most recent change of +$7.58 billion (+460.69%) on December 31, 2024.
  • Over the past year, ABT quarterly net income has increased by +$7.63 billion (+478.98%).
  • ABT quarterly net income is now at all-time high.

Performance

ABT quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

TTM net income:

$13.40B+$7.63B(+132.39%)
December 31, 2024

Summary

  • As of today (April 16, 2025), ABT TTM net profit is $13.40 billion, with the most recent change of +$7.63 billion (+132.39%) on December 31, 2024.
  • Over the past year, ABT TTM net income has increased by +$7.68 billion (+134.18%).
  • ABT TTM net income is now at all-time high.

Performance

ABT TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ABT Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+134.2%+479.0%+134.2%
3 y3 years+89.5%+479.0%+134.2%
5 y5 years+263.5%+479.0%+134.2%

ABT Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+134.2%at high+793.4%at high+159.7%
5 y5-yearat high+263.5%at high+1618.6%at high+330.9%
alltimeall timeat high+3228.9%at high+1214.6%at high>+9999.0%

Abbott Laboratories Net income History

DateAnnualQuarterlyTTM
Dec 2024
$13.40B(+134.2%)
$9.23B(+460.7%)
$13.40B(+132.4%)
Sep 2024
-
$1.65B(+26.4%)
$5.77B(+3.8%)
Jun 2024
-
$1.30B(+6.3%)
$5.56B(-1.3%)
Mar 2024
-
$1.23B(-23.1%)
$5.63B(-1.6%)
Dec 2023
$5.72B(-17.5%)
$1.59B(+11.0%)
$5.72B(+10.9%)
Sep 2023
-
$1.44B(+4.4%)
$5.16B(+0.0%)
Jun 2023
-
$1.38B(+4.3%)
$5.16B(-11.1%)
Mar 2023
-
$1.32B(+27.6%)
$5.80B(-16.3%)
Dec 2022
$6.93B(-2.0%)
$1.03B(-28.0%)
$6.93B(-12.1%)
Sep 2022
-
$1.44B(-28.9%)
$7.89B(-7.8%)
Jun 2022
-
$2.02B(-17.5%)
$8.55B(+10.7%)
Mar 2022
-
$2.45B(+23.0%)
$7.72B(+9.2%)
Dec 2021
$7.07B(+57.3%)
$1.99B(-5.3%)
$7.07B(-2.4%)
Sep 2021
-
$2.10B(+76.6%)
$7.24B(+13.6%)
Jun 2021
-
$1.19B(-33.7%)
$6.38B(+11.4%)
Mar 2021
-
$1.79B(-17.1%)
$5.72B(+27.3%)
Dec 2020
$4.50B(+21.9%)
$2.16B(+75.5%)
$4.50B(+32.9%)
Sep 2020
-
$1.23B(+129.4%)
$3.38B(+8.7%)
Jun 2020
-
$537.00M(-4.8%)
$3.11B(-13.1%)
Mar 2020
-
$564.00M(-46.2%)
$3.58B(-2.9%)
Dec 2019
$3.69B(+55.7%)
$1.05B(+9.3%)
$3.69B(+12.0%)
Sep 2019
-
$960.00M(-4.6%)
$3.29B(+13.7%)
Jun 2019
-
$1.01B(+49.7%)
$2.90B(+10.4%)
Mar 2019
-
$672.00M(+2.8%)
$2.62B(+10.7%)
Dec 2018
$2.37B(+396.4%)
$654.00M(+16.2%)
$2.37B(+167.3%)
Sep 2018
-
$563.00M(-23.2%)
$886.00M(-4.3%)
Jun 2018
-
$733.00M(+75.4%)
$926.00M(+94.5%)
Mar 2018
-
$418.00M(-150.5%)
$476.00M(-0.2%)
Dec 2017
$477.00M(-65.9%)
-$828.00M(-237.3%)
$477.00M(-77.3%)
Sep 2017
-
$603.00M(+113.1%)
$2.10B(+79.6%)
Jun 2017
-
$283.00M(-32.5%)
$1.17B(-22.1%)
Mar 2017
-
$419.00M(-47.5%)
$1.50B(+7.4%)
Dec 2016
$1.40B(-68.3%)
$798.00M(-342.6%)
$1.40B(+2.3%)
Sep 2016
-
-$329.00M(-153.5%)
$1.37B(-39.9%)
Jun 2016
-
$615.00M(+94.6%)
$2.28B(-6.9%)
Mar 2016
-
$316.00M(-58.8%)
$2.45B(-44.7%)
Dec 2015
$4.42B(+93.7%)
$767.00M(+32.2%)
$4.42B(-3.0%)
Sep 2015
-
$580.00M(-26.0%)
$4.56B(+0.9%)
Jun 2015
-
$784.00M(-65.8%)
$4.52B(+7.6%)
Mar 2015
-
$2.29B(+153.5%)
$4.20B(+84.0%)
Dec 2014
$2.28B(-11.3%)
$904.00M(+68.0%)
$2.28B(+16.0%)
Sep 2014
-
$538.00M(+15.5%)
$1.97B(-17.9%)
Jun 2014
-
$466.00M(+24.3%)
$2.40B(-0.4%)
Mar 2014
-
$375.00M(-36.3%)
$2.41B(-6.6%)
Dec 2013
$2.58B(-56.8%)
$589.00M(-39.0%)
$2.58B(-15.3%)
Sep 2013
-
$966.00M(+102.9%)
$3.04B(-24.3%)
Jun 2013
-
$476.00M(-12.5%)
$4.02B(-23.7%)
Mar 2013
-
$544.00M(-48.4%)
$5.26B(-11.7%)
Dec 2012
$5.96B(+26.1%)
$1.05B(-45.8%)
$5.96B(-8.7%)
Sep 2012
-
$1.94B(+12.7%)
$6.53B(+33.5%)
Jun 2012
-
$1.72B(+38.8%)
$4.89B(-4.3%)
Mar 2012
-
$1.24B(-23.2%)
$5.11B(+8.0%)
Dec 2011
$4.73B(+2.2%)
$1.62B(+433.7%)
$4.73B(+3.9%)
Sep 2011
-
$303.18M(-84.4%)
$4.55B(-11.4%)
Jun 2011
-
$1.94B(+124.9%)
$5.14B(+14.5%)
Mar 2011
-
$863.82M(-40.0%)
$4.49B(-3.0%)
Dec 2010
$4.63B(-19.5%)
$1.44B(+61.8%)
$4.63B(-2.1%)
Sep 2010
-
$890.66M(-31.0%)
$4.72B(-11.1%)
Jun 2010
-
$1.29B(+28.8%)
$5.31B(+0.1%)
Mar 2010
-
$1.00B(-34.8%)
$5.31B(-7.6%)
Dec 2009
$5.75B(+17.7%)
$1.54B(+3.9%)
$5.75B(+0.0%)
Sep 2009
-
$1.48B(+14.9%)
$5.74B(+7.4%)
Jun 2009
-
$1.29B(-10.5%)
$5.35B(-0.6%)
Mar 2009
-
$1.44B(-6.4%)
$5.38B(+10.3%)
Dec 2008
$4.88B(+35.3%)
$1.54B(+41.6%)
$4.88B(+7.3%)
Sep 2008
-
$1.08B(-18.0%)
$4.55B(+8.8%)
Jun 2008
-
$1.32B(+41.0%)
$4.18B(+8.7%)
Mar 2008
-
$937.87M(-22.0%)
$3.85B(+6.7%)
Dec 2007
$3.61B(+110.1%)
$1.20B(+67.8%)
$3.61B(+87.1%)
Sep 2007
-
$717.00M(-27.5%)
$1.93B(+0.1%)
Jun 2007
-
$988.74M(+41.7%)
$1.93B(+24.3%)
Mar 2007
-
$697.54M(-246.5%)
$1.55B(-9.7%)
Dec 2006
$1.72B(-49.1%)
-$476.21M(-166.5%)
$1.72B(-45.8%)
Sep 2006
-
$715.84M(+16.9%)
$3.17B(+1.1%)
Jun 2006
-
$612.24M(-29.2%)
$3.13B(-7.8%)
Mar 2006
-
$864.88M(-11.4%)
$3.40B(+0.8%)
Dec 2005
$3.37B(+4.2%)
$976.42M(+43.4%)
$3.37B(+0.1%)
Sep 2005
-
$680.71M(-22.4%)
$3.37B(-3.5%)
Jun 2005
-
$877.05M(+4.7%)
$3.49B(+7.5%)
Mar 2005
-
$837.89M(-14.0%)
$3.25B(+0.5%)
Dec 2004
$3.24B
$974.61M(+21.2%)
$3.24B(+0.9%)
Sep 2004
-
$804.08M(+26.8%)
$3.21B(+1.4%)
DateAnnualQuarterlyTTM
Jun 2004
-
$634.26M(-22.9%)
$3.16B(+14.0%)
Mar 2004
-
$822.91M(-12.9%)
$2.78B(+0.8%)
Dec 2003
$2.75B(-1.4%)
$944.39M(+24.1%)
$2.75B(+13.0%)
Sep 2003
-
$761.22M(+208.6%)
$2.44B(+1.7%)
Jun 2003
-
$246.64M(-69.2%)
$2.39B(-12.6%)
Mar 2003
-
$800.98M(+27.7%)
$2.74B(-1.9%)
Dec 2002
$2.79B(+80.2%)
$627.11M(-12.9%)
$2.79B(+0.5%)
Sep 2002
-
$720.05M(+21.6%)
$2.78B(+3.3%)
Jun 2002
-
$592.26M(-30.7%)
$2.69B(+2.4%)
Mar 2002
-
$854.28M(+39.2%)
$2.63B(+69.5%)
Dec 2001
$1.55B(-44.4%)
$613.55M(-2.8%)
$1.55B(-8.3%)
Sep 2001
-
$631.40M(+19.3%)
$1.69B(-1.3%)
Jun 2001
-
$529.05M(-336.6%)
$1.71B(-8.4%)
Mar 2001
-
-$223.61M(-129.7%)
$1.87B(-32.9%)
Dec 2000
$2.79B(+13.9%)
$753.40M(+15.1%)
$2.79B(+3.3%)
Sep 2000
-
$654.42M(-4.5%)
$2.70B(+7.4%)
Jun 2000
-
$685.20M(-1.1%)
$2.51B(+1.6%)
Mar 2000
-
$692.96M(+4.4%)
$2.47B(+1.0%)
Dec 1999
$2.45B(+4.8%)
$664.04M(+41.9%)
$2.45B(+1.5%)
Sep 1999
-
$468.08M(-27.4%)
$2.41B(-2.6%)
Jun 1999
-
$645.00M(-3.5%)
$2.47B(+2.5%)
Mar 1999
-
$668.70M(+6.6%)
$2.41B(+3.4%)
Dec 1998
$2.33B(+12.3%)
$627.50M(+18.0%)
$2.33B(+3.4%)
Sep 1998
-
$531.70M(-9.2%)
$2.26B(+2.7%)
Jun 1998
-
$585.57M(-0.7%)
$2.20B(+3.0%)
Mar 1998
-
$589.60M(+6.9%)
$2.13B(+2.6%)
Dec 1997
$2.08B(+10.5%)
$551.30M(+16.9%)
$2.08B(+2.0%)
Sep 1997
-
$471.40M(-9.6%)
$2.04B(+2.5%)
Jun 1997
-
$521.53M(-2.5%)
$1.99B(+2.6%)
Mar 1997
-
$534.83M(+4.7%)
$1.94B(+2.9%)
Dec 1996
$1.88B(+11.4%)
$510.58M(+21.3%)
$1.88B(+2.5%)
Sep 1996
-
$420.89M(-10.5%)
$1.84B(+2.2%)
Jun 1996
-
$470.40M(-2.0%)
$1.80B(+2.6%)
Mar 1996
-
$480.10M(+3.2%)
$1.75B(+3.7%)
Dec 1995
$1.69B(+11.3%)
$465.37M(+21.8%)
$1.69B(+2.6%)
Sep 1995
-
$382.05M(-9.9%)
$1.65B(+1.9%)
Jun 1995
-
$424.03M(+1.6%)
$1.62B(+3.0%)
Mar 1995
-
$417.25M(-1.3%)
$1.57B(+3.4%)
Dec 1994
$1.52B(+8.4%)
$422.55M(+20.3%)
$1.52B(+2.1%)
Sep 1994
-
$351.34M(-6.7%)
$1.49B(+2.4%)
Jun 1994
-
$376.56M(+2.8%)
$1.45B(+2.1%)
Mar 1994
-
$366.23M(-6.4%)
$1.42B(+1.5%)
Dec 1993
$1.40B(+12.9%)
$391.33M(+23.8%)
$1.40B(+3.1%)
Sep 1993
-
$316.20M(-8.6%)
$1.36B(+2.8%)
Jun 1993
-
$346.10M(+0.2%)
$1.32B(+2.2%)
Mar 1993
-
$345.50M(-1.0%)
$1.29B(+4.1%)
Dec 1992
$1.24B(+13.8%)
$349.00M(+25.2%)
$1.24B(+2.8%)
Sep 1992
-
$278.80M(-12.1%)
$1.20B(+2.3%)
Jun 1992
-
$317.10M(+7.8%)
$1.18B(+4.3%)
Mar 1992
-
$294.20M(-6.5%)
$1.13B(+3.7%)
Dec 1991
$1.09B(+12.7%)
$314.80M(+25.1%)
$1.09B(+3.3%)
Sep 1991
-
$251.60M(-6.2%)
$1.05B(+3.0%)
Jun 1991
-
$268.30M(+5.6%)
$1.02B(+2.8%)
Mar 1991
-
$254.10M(-9.2%)
$994.90M(+3.0%)
Dec 1990
$965.80M(+12.3%)
$279.80M(+26.7%)
$965.80M(+2.9%)
Sep 1990
-
$220.80M(-8.1%)
$939.00M(+2.7%)
Jun 1990
-
$240.20M(+6.8%)
$914.50M(+3.1%)
Mar 1990
-
$225.00M(-11.1%)
$886.90M(+3.1%)
Dec 1989
$859.80M(+14.3%)
$253.00M(+28.9%)
$859.90M(+3.7%)
Sep 1989
-
$196.30M(-7.7%)
$829.20M(+3.0%)
Jun 1989
-
$212.60M(+7.4%)
$805.20M(+3.5%)
Mar 1989
-
$198.00M(-10.9%)
$777.90M(+3.4%)
Dec 1988
$752.00M(+18.9%)
$222.30M(+29.0%)
$752.00M(+4.5%)
Sep 1988
-
$172.30M(-7.0%)
$719.80M(+3.8%)
Jun 1988
-
$185.30M(+7.7%)
$693.30M(+4.6%)
Mar 1988
-
$172.10M(-9.5%)
$663.10M(+4.8%)
Dec 1987
$632.60M(+17.0%)
$190.10M(+30.4%)
$632.60M(+4.9%)
Sep 1987
-
$145.80M(-6.0%)
$603.10M(+4.0%)
Jun 1987
-
$155.10M(+9.5%)
$580.10M(+3.8%)
Mar 1987
-
$141.60M(-11.8%)
$558.60M(+3.3%)
Dec 1986
$540.50M(+16.2%)
$160.60M(+30.8%)
$540.50M(+3.7%)
Sep 1986
-
$122.80M(-8.1%)
$521.30M(+3.2%)
Jun 1986
-
$133.60M(+8.2%)
$505.20M(+3.8%)
Mar 1986
-
$123.50M(-12.7%)
$486.60M(+4.6%)
Dec 1985
$465.30M(+15.6%)
$141.40M(+32.5%)
$465.30M(+4.1%)
Sep 1985
-
$106.70M(-7.2%)
$447.00M(+3.5%)
Jun 1985
-
$115.00M(+12.5%)
$431.70M(+3.5%)
Mar 1985
-
$102.20M(-17.0%)
$417.10M(+3.6%)
Dec 1984
$402.60M
$123.10M(+34.7%)
$402.60M(+44.0%)
Sep 1984
-
$91.40M(-9.0%)
$279.50M(+48.6%)
Jun 1984
-
$100.40M(+14.5%)
$188.10M(+114.5%)
Mar 1984
-
$87.70M
$87.70M

FAQ

  • What is Abbott Laboratories annual net profit?
  • What is the all time high annual net income for Abbott Laboratories?
  • What is Abbott Laboratories annual net income year-on-year change?
  • What is Abbott Laboratories quarterly net profit?
  • What is the all time high quarterly net income for Abbott Laboratories?
  • What is Abbott Laboratories quarterly net income year-on-year change?
  • What is Abbott Laboratories TTM net profit?
  • What is the all time high TTM net income for Abbott Laboratories?
  • What is Abbott Laboratories TTM net income year-on-year change?

What is Abbott Laboratories annual net profit?

The current annual net income of ABT is $13.40B

What is the all time high annual net income for Abbott Laboratories?

Abbott Laboratories all-time high annual net profit is $13.40B

What is Abbott Laboratories annual net income year-on-year change?

Over the past year, ABT annual net profit has changed by +$7.68B (+134.18%)

What is Abbott Laboratories quarterly net profit?

The current quarterly net income of ABT is $9.23B

What is the all time high quarterly net income for Abbott Laboratories?

Abbott Laboratories all-time high quarterly net profit is $9.23B

What is Abbott Laboratories quarterly net income year-on-year change?

Over the past year, ABT quarterly net profit has changed by +$7.63B (+478.98%)

What is Abbott Laboratories TTM net profit?

The current TTM net income of ABT is $13.40B

What is the all time high TTM net income for Abbott Laboratories?

Abbott Laboratories all-time high TTM net profit is $13.40B

What is Abbott Laboratories TTM net income year-on-year change?

Over the past year, ABT TTM net profit has changed by +$7.68B (+134.18%)
On this page